Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020.,American Journal of Clinical Oncology

当前位置： X-MOL 学术 › Am. J. Clin. Oncol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020.
American Journal of Clinical Oncology ( IF 2.6 ) Pub Date : 2023-07-31 , DOI: 10.1097/coc.0000000000001031
Ricardo García-Fumero ₁ , Cristina Fernández-López ₂ , Miguel Ángel Calleja-Hernández _{3,

4} , Manuela Expósito-Ruiz ₄ , Jaime Espín _{5,

6,

7} , José Expósito-Hernández ₈

Affiliation

To analyze the evolution of clinical outcomes derived from clinical trials on first-line therapies for advanced or metastatic non-small cell lung cancer (NSCLC) published between 2010 and 2020, focusing on how these outcomes impact survival rates and management of patients.

中文翻译：